Dr. William Shrank is serving as Venture Partner, Bio and Health at Andreessen Horowitz. Previously,
Dr. Shrank served as Chief Medical Officer for Humana, where his responsibilities included implementing Humanas integrated care delivery strategy, with an emphasis on advancing the Companys clinical capabilities and core objective
of improving the health outcomes. He led Humanas Care Delivery Organization, clinical operations, health equity, and the Bold Goal population health strategy. Dr. Shrank previously held the position of Chief Medical and Corporate Affairs
Officer (July 2019-July 2021) during which time he oversaw government affairs.
Dr. Shrank joined Humana in April 2019, having previously been
employed by the University of Pittsburgh Medical Center (UPMC) where he served as Chief Medical Officer, Insurance Services Division from 2016 to 2019. At UPMC, Dr. Shrank was responsible for clinical operations, policy and quality for
approximately 3.5 million members in Medicare, Medicaid, behavioral health, Managed Long Term Social Supports and commercial lines of business. He also developed and evaluated population health programs to further advance the medical
centers mission as an integrated delivery and financing system.
Previously, Dr. Shrank served as Senior Vice President, Chief Scientific
Officer, and Chief Medical Officer of Provider Innovation at CVS Health from 2013 to 2016. Prior to joining CVS Health, Dr. Shrank served as Director, Research and Rapid-Cycle Evaluation Group, for the Center for Medicare and Medicaid
Innovation, part of the Centers for Medicaid and Medicare Services (CMS) from 2011 to 2013, where he led the evaluation of all payment and health system delivery reform programs and developed the rapid-cycle strategy to promote continuous quality
improvement.
Dr. Shrank began his career as a practicing physician with Brigham and Womens Hospital in Boston and as an Assistant Professor at
Harvard Medical School. His research at Harvard focused on improving the quality of prescribing and the use of chronic medications. He has published more than 275 papers on these topics.
About WW International, Inc.
WeightWatchers is a
human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management program. For six decades, we have inspired millions of people to adopt healthy habits for real life. We combine technology
and community to help members reach and sustain their goals on our program. To learn more about the WeightWatchers approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at
corporate.ww.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on managements current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important
factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws
contain discussions of these risks and uncertainties. The Company assumes no obligation to, and